By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Celera today reported that its fourth-quarter sales fell 11 percent as its licensing revenues declined sharply year over year.

The Alameda, Calif.-based molecular diagnostics firm, which announced separately that it will be acquired by Quest Diagnostics for $671 million, brought in total revenues of $34.9 million for the three-month period ended Dec. 25, compared to $39.2 million for Q4 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.